RACHEL FORD: Open Payments
NPI 1154479764 · CLIVE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,759 in 99 payments from 18 companies in 2025. Trend: 2023 $2,442 · 2024 $2,033 · 2025 $1,759
Food & beverage: $1,759
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $415 |
| ABBVIE INC. | 18 | $248 |
| Novartis Pharmaceuticals Corporation | 12 | $161 |
| E.R. Squibb & Sons, L.L.C. | 13 | $156 |
| Lilly USA, LLC | 7 | $153 |
| Amgen Inc. | 4 | $82 |
| Incyte Corporation | 3 | $80 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $74 |
| Organon LLC | 4 | $69 |
| Arcutis Biotherapeutics, Inc. | 4 | $69 |
Products named: Bimzelx, SKYRIZI, Sotyktu, TALTZ, COSENTYX, OTEZLA, OPZELURA, ILUMYA.
Industry payments across IA — which companies pay providers there.
